The CAG Repeat Story: How AR Gene Length Predicts Balding Risk

Shorter CAG repeats in the AR gene produce a more transcriptionally active androgen receptor. This single genetic variable explains a meaningful proportion of variance in AGA severity between men with otherwise similar androgen profiles.

The polyglutamine repeat in the androgen receptor's N-terminal domain is one of the clearest molecular links between AR gene structure and androgenic phenotype. Its relationship to AGA is direct and mechanistically well-characterised, making it one of the most studied genetic contributors to male pattern hair loss.

The polyglutamine domain and receptor function

The N-terminal domain (NTD) of the androgen receptor contains a polyglutamine stretch encoded by the CAG repeat in exon 1. This polyQ tract participates in the intramolecular N/C interaction — the folding relationship between the NTD and the ligand-binding domain that occurs when DHT is bound. The length of the polyQ tract affects how efficiently this N/C interaction occurs, which in turn affects transcriptional activation efficiency.

Shorter polyQ (fewer CAG repeats): more efficient N/C interaction, stronger coactivator recruitment, higher transcriptional output per DHT molecule bound. Longer polyQ (more repeats): less efficient N/C interaction, reduced coactivator binding, lower transcriptional output. The effect is graded rather than binary — each repeat length change shifts activity modestly, but across the population-level range (typically 9–36 repeats in most studies), the cumulative effect is clinically meaningful.

AGA correlation data

Multiple epidemiological studies have confirmed inverse correlation between CAG repeat length and AGA severity: men with shorter repeats have earlier onset and more extensive pattern loss on average. The correlation is modest at the individual level — CAG repeat length is one factor among several, and high AR sensitivity can be partially offset by lower DHT production or other genetic protective factors. But across populations, the direction of the effect is consistent and the mechanism is coherent.

The prostate connection

The same CAG repeat length that correlates with AGA severity also correlates with prostate cancer risk — shorter repeats associate with more aggressive prostate cancer in several large epidemiological datasets. This shared genetic influence via AR activity underscores why AGA and prostate responsiveness to androgens often co-segregate, and it has implications for thinking about long-term AR targeting in AGA treatment.